Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 02 May 2017
At a glance
- Drugs Gallium 68-DOTATOC (Primary)
- Indications Brain cancer
- Focus Diagnostic use
- 27 Apr 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2017.
- 27 Apr 2017 Status changed from suspended to withdrawn prior to enrolment.
- 07 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2018.